Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: A randomized, controlled trial

Annals of Internal Medicine

Volumn 126, Issue 11, 1997, Pages 858-865

  Cello, John P ^h   Ring, Ernest J ^h   Olcott, Eric W ^a   Koch, Johannes ^h   Gordon, Roy ^h   Sandhu, Jeet ^b   Morgan, Douglas R ^c   Ostroff, James W ^d   Rockey, Don C ^e   Bacchetti, Peter ^d   LaBerge, Jeanne ^h   Lake, John R ^d   Somberg, Kenneth ^d   Doherty, Catherine ^d   Davila, Marta ^f   McQuaid, Kenneth ^g   Wall, Susan D ^h  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^g SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; HEPATIC VEIN; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTICENTER STUDY; PORTAL VEIN; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCLEROTHERAPY; SURVIVAL RATE; VARICOSIS;

EID: 0030952064     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-11-199706010-00002     Document Type: Article

References (18)

1. Cello JP, Grendell JH, Crass RA, Trunkey DD, Cobb EE, Heilbron DC. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl J Med. 1984;311:1589-94.
2. Cello JP, Grendell JH, Crass RA, Weber TE, Trunkey DD. Endoscopic sclerotherapy versus portacaval shunt in patient with severe cirrhosis and variceal hemorrhage. Long-term follow-up. N Engl J Med. 1987;316:11-5.
3. LaBerge JM, Ring EJ, Gordon RL, Lake JR, Doherty MM, Somberg KA, et al. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology. 1993;187:413-20.
4. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med. 1994;330:165-71.
5. Sanyal AJ, Freedman AM, Purdum PP, Luketic VA, Shiffman MI, Tisnado J, et al. Transjugular intrahepatic portosystemic shunt (TIPS) vs. sclerotherapy for prevention of recurrent variceal hemorrhage: a randomized prospective trial [Abstract]. Gastroenterology. 1994;106:A975.
6. Cabrera J, Maynar M, Granados R, Gorriz E, Reyes R, Pulido-Duque JM, et al. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology. 1996; 110:832-9.
7. Merli M, Riggio O, Capocaccia L, Rossi P, Salerno F, DeFranchis R, et al. TIPS vs. sclerotherapy for prevention of variceal rebleeding: results of a randomized controlled trial [Abstract]. Gastroenterology. 1996;110:A1265.
8. Sauer P, Theilmann L, Benz C, Roeren T, Richter G, Stremmel W, et al. Transjugular intrahepatic portosystemic stent shunt (TIPS) vs. sclerotherapy in the prevention of variceal rebleeding: a randomized study. Gastroenterology. 1996;110:A1313.
9. Rossle M, Deibert P, Haag K, Ochs A, Siegerstetter V, Langer M. TIPS versus sclerotherapy and β-blockade: preliminary results of a randomized study in patients with recurrent variceal hemorrhage [Abstract]. Hepatology. 1994;20:107A.
10. Groupe D'Etude des Anastomoses Intra-Hepatiques. TIPS vs. sclerotherapy and propanolol in the prevention of variceal rebleeding; preliminary results of a multicenter randomized trial [Abstract]. Hepatology. 1995;22:297A.
11. Pugh RN. Pugh's grading in the classification of liver decompensation [Letter]. Gut. 1992;33:1583.
12. Breslow NE. Covariance analysis of censored survival data. Biometrics. 1974; 30:89-9.
13. Harrell FE, Kee KL. Verifying assumptions of the Cox proportional hazards model. In: Proceedings of the 11th Annual SAS User's Group International Conference. Cary, NC: SAS Institute; 1986.
14. Lo GH, Lai KH, Cheng JS, Hwu JH, Chang CF, Chen SM, et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology. 1995;22:477-81.
15. Gimson AE, Ramage JK, Panos MZ, Hayllar K, Harrison PM, Williams R, et al. Randomised trial of variceal band ligation versus injection sclerotherapy for bleeding oesophageal varices. Lancet. 1993;342:391-4.
16. Laine L, el-Newihi HM, Migikovsky B, Sloane R, Garcia F. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices Ann Intern Med 1993;119:1-7.
17. Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med. 1992;326:1527-32.
18. Somberg KA, Riegler JL, La Berge JM. Hepatic encephalopathy following transjugular intrahepatic portosystemic shunts (TIPS): incidence and risk factors. Am J Gastroenterol. 1995;90:549-55.